Neurology
RSSArticles
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Preparing for the Possibility of a Bird Flu Pandemic
The possibility of a bird flu pandemic has health officials worldwide in a high state of alert. -
After Vioxx: The Issue of Safety in Prescribing COX-2 Inhibitors
After the voluntary withdrawal of Vioxx from the market in September 2004 following reports of increased cardiovascular events associated with the drug, there was a call from some quarters for a similar action for all selective COX-2 inhibitors (coxibs). This article reviews the current clinical knowledge regarding the coxibs and their cardiovascular effects. Recommendations for prescribing anti-inflammatory drugs in common clinical situations are provided. -
Full April 18, 2005
-
Full April 15, 2005, Issue in PDF
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Preparing for the Possibility of a Bird Flu Pandemic
The possibility of a bird flu pandemic has health officials worldwide in a high state of alert. -
ECG Review: When to Pace Sick Sinus?
The non-continuous lead II rhythm strips shown in the Figure were obtained from an asymptomatic 76-year-old woman. Are these rhythms diagnostic (or at least consistent) with sick sinus syndrome? Is permanent pacemaker implantation indicated? On what does your answer depend? -
Clinical Briefs
Although all strokes are potentially debilitating, intracerebral hemorrhage is often the most disabling. -
Pharmacology Update: Palifermin Injection (KepivanceTM)
Amgen has received approval to market palifermin. The drug is approved to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies undergoing chemotherapy, with or without radiation, followed by a bone marrow transplant.